SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Hologic, Inc. (HOLX) trades at a trailing P/E of 31.4, forward P/E of 17.2. Trailing earnings yield is 3.19%, forward earnings yield 5.81%. PEG 0.22 (Peter Lynch undervalued ≤1.0). Graham Number is $35.70.
Criteria proven by this page:
- VALUE (35/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
- Forward P/E 17.2 (down from trailing 31.4) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.22 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 3.19% — roughly competitive with bond yields (~4.3%), moderate risk-reward. Forward yield improves to 5.81% as earnings recover.
- Analyst consensus target $77.75 (+2.3% upside) — modest upside expected.
Overall SharesGrow Score: 57/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
35/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
83/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — HOLX
Valuation Multiples
P/E (TTM)31.4
Forward P/E17.2
PEG Ratio0.22
Forward PEG0.22
P/B Ratio3.25
P/S Ratio4.11
EV/EBITDA17.1
Per Share Data
EPS (TTM)$2.42
Forward EPS (Est.)$4.42
Book Value / Share$23.37
Revenue / Share$18.39
FCF / Share$4.45
Yields & Fair Value
Earnings Yield3.19%
Forward Earnings Yield5.81%
Dividend Yield0.00%
Graham Number$35.70
SharesGrow IV$104.62 (+37.6%)
Analyst Target$77.75 (+2.3%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
32.9 |
0.22 |
5.08 |
3.84 |
- |
| 2017 |
13.6 |
0.11 |
3.69 |
3.36 |
- |
| 2018 |
-101.4 |
0.88 |
4.65 |
3.51 |
- |
| 2019 |
-338.4 |
5.41 |
5.97 |
4.04 |
- |
| 2020 |
15.7 |
-0.01 |
6.46 |
4.62 |
- |
| 2021 |
10.1 |
0.14 |
4.50 |
3.37 |
- |
| 2022 |
12.5 |
-0.43 |
3.33 |
3.34 |
- |
| 2023 |
37.6 |
-0.58 |
3.41 |
4.25 |
- |
| 2024 |
24.3 |
0.30 |
3.74 |
4.76 |
- |
| 2025 |
27.0 |
-1.06 |
3.02 |
3.72 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$1.16 |
$2.83B |
$330.8M |
11.7% |
| 2017 |
$2.64 |
$3.06B |
$755.5M |
24.7% |
| 2018 |
$-0.40 |
$3.22B |
$-111.3M |
-3.5% |
| 2019 |
$-0.15 |
$3.37B |
$-40.2M |
-1.2% |
| 2020 |
$4.21 |
$3.78B |
$1.12B |
29.5% |
| 2021 |
$7.21 |
$5.63B |
$1.87B |
33.2% |
| 2022 |
$5.13 |
$4.86B |
$1.3B |
26.8% |
| 2023 |
$1.83 |
$4.03B |
$456M |
11.3% |
| 2024 |
$3.32 |
$4.03B |
$789.5M |
19.6% |
| 2025 |
$2.49 |
$4.1B |
$565.7M |
13.8% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$4.42 |
$4.28 – $4.56 |
$4.2B |
$4.11B – $4.24B |
10 |
| 2027 |
$4.80 |
$4.50 – $5.08 |
$4.41B |
$4.29B – $4.48B |
7 |
| 2028 |
$5.17 |
$4.46 – $5.88 |
$4.6B |
$4.55B – $4.65B |
5 |
| 2029 |
$5.75 |
$5.58 – $5.87 |
$4.9B |
$4.8B – $4.98B |
1 |
